In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cadence Pharmaceuticals Inc.

Division of Mallinckrodt PLC

Latest From Cadence Pharmaceuticals Inc.

Interview: Acacia Seeks Access All Areas For PONV Drug Barhemsys

Acacia's bids to get the thumbs-up in the US for its post-operative nausea and vomiting therapy have finally borne fruit. CEO Mile Bolinder tells Scrip that his experienced team is now firmly focused on gaining as many hospital formulary approvals as possible for Barhemsys.

Market Access Approvals

Nabriva Gains New CEO And Near-Market Antibiotic, Claims Leadership Role

The acquisition of Zavante Therapeutics and its late-stage investigational intravenous antibiotic for use in multi-drug resistant pathogens has also led to C-suite change at Nabriva Therapeutics.

M & A Infectious Diseases

Deal Watch: Endo Elbows In On Valeant’s Pursuit Of Salix

Bristol options rights to investigational prostate cancer immunotherapy, giving Bavarian Nordic additional funding to develop the candidate. Targacept finally calls it a day, in a reverse merger with Catalyst, while Arrowhead buys out the RNAi assets of Novartis.

BioPharmaceutical Deals

Acacia names new board members

Acacia Pharma, a company specializing in the development of drugs for supportive care, has named Scott Byrd and Christine Soden to its board of directors. Mr Byrd was most recently the chief commercial officer of Cadence Pharmaceuticals until the company's acquisition by Mallinckrodt Pharmaceuticals in March 2014.  Previously, Mr Byed held a variety of US and global roles in sales, marketing, finance, manufacturing and strategic planning at Lilly.

See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Strata Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mallinckrodt PLC
  • Senior Management
  • Theodore R Schroeder, Pres. & CEO
    William R LaRue, SVP, CFO, Treasurer & Asst. Secretary
    Scott Byrd, SVP, Chief Commercial Officer
  • Contact Info
  • Cadence Pharmaceuticals Inc.
    Phone: (858) 436-1400
    12481 High Bluff Dr.
    Ste. 200
    San Diego, CA 92130